| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |